G1 Therapeutics Stock Price, News & Analysis
Company Description
G1 Therapeutics (NASDAQ: GTHX) is a publicly traded pharmaceutical preparation manufacturing company in the Pharmaceutical Preparations sector. The company has a market capitalization of $377.2M, ranking #3,726 among all listed U.S. companies by market cap.
GTHX stock has gained 379.9% over the past year. Shares last traded at $7.15.
This page provides a comprehensive overview of GTHX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
G1 Therapeutics (GTHX) stock last traded at $7.15. Over the past 12 months, the stock has gained 379.9%. At a market capitalization of $377.2M, GTHX is classified as a small-cap stock with approximately 52.8M shares outstanding.
Latest News
G1 Therapeutics has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, acquisition, clinical trial. View all GTHX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GTHX Company Profile & Sector Positioning
G1 Therapeutics (GTHX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.